sii diphtheria & tetanus vaccine adsorbed(pediatric) >25lf(>30iu)+>5lf(>40iu) adsorbed on ?1.5mg parenteral ordinary ampoules
serum institute of india ltd. - diptheria toxoid+tetanus toxoid adsorbed on aluminium phosphate - parenteral ordinary ampoules - >25lf(>30iu)+>5lf(>40iu) adsorbed on ?1.5mg
sii diphtheriatetanus &pertussis vaccine adsorbed-20 doses
sm pharmaceuticals sdn. bhd. - tetanus toxoid; diphtheria toxoid; pertussis vaccine (adsorbed) -
csl tetanus immunoglobulin vf (human) 250iu injection vial
csl behring australia pty ltd - tetanus immunoglobulin, quantity: 250 iu; human immunoglobulin g, quantity: 160 mg/ml - injection, solution - excipient ingredients: glycine; human immunoglobulin a - tetanus immunoglobulin is indicated for the passive protection of individuals who have sustained a tetanus-prone wound and who have either not been actively immunised against tetanus or whose immunisation history is doubtful. it should also be given to the fully immunised patient with a tetanus-prone wound if more than 10 years have elapsed since the last dose of toxoid. in all the above instances, active immunisation with tetanus toxoid, adsorbed or adt vaccine should be commenced at the same time [in accordance with details specified in table 1 (guide to tetanus prophylaxis in wound management) in indication section of the approved product information provided as attachment 1]. although tetanus immunoglobulin and vaccine should be given at the same time, they should be administered in opposite limbs, using separate syringes.
tt vax vaccine
popular pharmaceuticals ltd. - adsorbed tetanus vaccine - vaccine - 5 lf/.5 ml
tetavax suspension for injection in pre-filled syringe, adsorbed tetanus vaccine
jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - tetanus toxoid, aluminium hydroxide, hydrated - suspension for injection - tetanus toxoid 40 iu aluminium hydroxide, hydrated 0.6 mg - vaccines
adsorbed tetanus vaccine bp suspension for injection ,
biological e. limited, india - tetanus toxoid - suspension for injection - ,
tetanus toxoid vaccine adsorbed
serum institute of india ltd - adsorbed tetanus toxoid - injection - each single 0.5 ml human dose contains adsorbed tetanus toxoid ? 5 lf (? 40 iu)
triaxis, suspension for injection in a pre-filled syringediphtheria, tetanus, pertussis (acellular component) vaccine (adsorbed, reduced antigen(s) content)
sanofi pasteur - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin (prn); fimbriae types 2 and 3 - suspension for injection in pre-filled syringe - 0 international unit(s) - pertussis vaccines; pertussis, purified antigen, combinations with toxoids
revaxis suspension for injection in pre-filled syringe diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
sanofi pasteur - diphtheria toxoid; tetanus toxoid; poliovirus, type 1; poliovirus, type 2; poliovirus, type 3 - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-poliomyelitis-tetanus
adacel pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5ml injection vial
sanofi-aventis australia pty ltd - diphtheria toxoid, quantity: 2 iu; pertussis filamentous haemagglutinin, quantity: 5 microgram; pertussis toxoid, quantity: 2.5 microgram; pertussis fimbriae 2 + 3, quantity: 5 microgram; pertactin, quantity: 3 microgram; tetanus toxoid, quantity: 20 iu - injection, suspension - excipient ingredients: glutaral; formaldehyde; phenoxyethanol; water for injections; aluminium phosphate - adacel is indicated for active immunisation against tetanus, diphtheria and pertussis in persons aged 10 years and over as a booster following primary immunisation. adacel may be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.